Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cipla

Cipla

BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 18, 16:00
565.70
-7.65 (-1.33%)
VOLUME 95,241
LIVE
NSE
Aug 18, 15:58
565.30
-7.9 (-1.38%)
VOLUME 1,680,225
News on Cipla
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Cipla Ltd; target of Rs 627: KRChoksey

3.29 pm | 17 Aug 2017 |  Source: Moneycontrol.com

KRChoksey is bullish on Cipla Ltd has recommended buy rating on the stock with a target price of Rs 627 in its research report dated August 14, 2017....

Targeting 15% growth for FY18, export will pick up sizeably: Omkar Speciality 

1.10 pm | 17 Aug 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Pravin Herlekar, CMD of Omkar Speciality Chemicals discussed the company's Q1 performance....

Buy Cipla, Oil India, Petronet LNG; sell Larsen & Toubro, Raymond: Mitessh Thakkar 

10.33 am | 17 Aug 2017 |  Source: CNBC-TV18

Mitessh Thakkar of mitesshthakkar.com suggests buying Cipla, Oil India and Petronet LNG and advises selling Larsen & Toubro and Raymond....

Hold Cipla; target of Rs 525: ICICI Direct

4.27 pm | 16 Aug 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cipla with a target price of Rs 525 in its research report dated August 14, 2017....

Buy Cipla, Indusind Bank: Mitessh Thakkar 

3.26 pm | 16 Aug 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com suggests buying Cipla and Indusind Bank....

Cipla jumps 6% after management's FY18 outlook; analysts retain hold rating

1.54 pm | 14 Aug 2017 |  Source: Moneycontrol.com

With stock trading at 19x FY19 PE and growth dependent on the challenging US business, Jefferies said it maintained hold rating with increased target ...

Cipla: Outcome of AGM

11.12 am | 14 Aug 2017 |  Source: Moneycontrol.com

Proceedings of the 81st Annual General Meeting...

Cipla hopes to generate sustainable top-line growth in FY18

8.13 pm | 11 Aug 2017 |  Source: PTI

The company filed three products in Q1FY18 and filing is expected to intensity in the remaining part of the fiscal with a target to file 25 ANDAs in t...

Cipla: Outcome of board meeting

1.57 pm | 11 Aug 2017 |  Source: Moneycontrol.com

Please find attached letter dated 11th August 2017...

Cipla eyes filing over 20 ANDAs in US this fiscal

12.17 pm | 30 Jul 2017 |  Source: PTI

In the last financial year, the company had filed 32 abbreviated new drug applications (ANDAs) in the US....

Cipla gains 1% after launching anti-malaria drug for young children

2.39 pm | 26 Jul 2017 |  Source: Moneycontrol.com

The company has launched 100 mg Artesunate Rectocaps/Rectal Artesunate Suppositories (RAS), a life-saving, pre-referral intervention for the managemen...

Cipla announces launch of anti-malaria drug in Sub-Saharan Africa

9.32 pm | 25 Jul 2017 |  Source: Moneycontrol.com

Cipla has partnered with MMV, a leading product development partnership (PDP) in the field of antimalarial drugs to develop the RAS 100 mg....

Cipla's board meeting on August 11, 2017

2.40 pm | 19 Jul 2017 |  Source: Moneycontrol.com

Cipla has informed that the board meeting is scheduled to be held on August 11, 2017....

Hold Cipla; target of Rs 470: ICICI Direct

4.19 pm | 29 May 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Cipla with a target price of Rs 470 in its research report dated May 26, 2017....

Hold Cipla; target of Rs 510: Edelweiss

4.47 pm | 26 May 2017 |  Source: Moneycontrol.com

Edelweiss recommended hold rating on Cipla with a target price of Rs 510 in its research report dated May 25, 2017....

Cipla’s post Q4 net loss of Rs 61.8 cr; depreciation & impairment weigh in on financials 

4.58 pm | 25 May 2017 |  Source: Moneycontrol.com

The consolidated earnings before interest, taxes, depreciation and amortisation (EBITDA) came in at Rs 506.2 crore against Rs 176.1 crore during March...

Cipla Q4: Net profit seen at Rs 346.8 crore, revenues could rise to Rs 3,790 crore: Poll 

5.53 pm | 24 May 2017 |  Source: Moneycontrol.com

Meanwhile, the earnings before interest, taxes, depreciation and amortisation could come in at Rs 675.4 crore, while its operating margin is seen at 1...

Cipla Q4 PAT seen up 7.3% to Rs 326.3 cr: ICICI Securities

1.17 pm | 17 Apr 2017 |  Source: Moneycontrol.com

Net Sales are expected to increase by 5.6 percent Q-o-Q (up 17.9 percent Y-o-Y) to Rs 3852.5 crore, according to ICICI Securities. Cipla to report net...

1 2 3
Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.